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The gap junction gene Connexin31.1 has been reported to be expressed predominantly in the epidermis of murine skin. To study the function of
this gene, we generated mice in which the coding DNA of the Connexin31.1 gene was replaced by lacZ reporter coding DNA. Using β-
galactosidase staining, we have shown that lacZ/Connexin31.1 was expressed in the spinous and granular layers of the epidermis, in cells of
olfactory epithelium and in the vomeronasal organ. During embryogenesis, Connexin31.1 was co-expressed with another isoform, Connexin31, in
the post-implantation trophoblast cell lineage and, later in gestation, in placental glycogen cells. Although homozygous Connexin31.1-deficient
mice were fertile and showed no morphological or functional defects in adult organs expressing this gene, 30% of the offspring expected according
to Mendelian inheritance were lost between embryonic days 11.5 and 14.5 and surviving embryos were significantly reduced in weight near the end
of pregnancy. Placentas of Connexin31.1-deficient embryos were reduced in weight and showed altered morphology of the spongiotrophoblast and
labyrinth layer. The spongiotrophoblast formed a compact barrier at the decidual border that might restrict the maternal blood supply. We conclude
that Connexin31.1 is critical for normal placental development but appears to be functionally compensated by other connexin isoforms in the
embryo proper and adult mouse.
© 2007 Elsevier Inc. All rights reserved.Keywords: Gap junctions; Cx31.1; Placenta; Trophoblast; Glycogen cells; Olfactory epitheliumIntroduction
Connexin (Cx) proteins are subunits of gap junction
channels which permit diffusional exchange of ions, secondary
messenger molecules and metabolites (up to 1500 Da) between
two contacting cells. To date, 20 connexin (Cx) genes have
been identified in the mouse genome (Söhl and Willecke,⁎ Corresponding author. Fax: +49 228 734263.
E-mail address: genetik@uni-bonn.de (K. Willecke).
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0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.09.0252003). They show cell type and differentiation dependent
expression patterns, whereby most cell types express more than
one connexin isoform. Cx proteins can assemble into
homomeric or heteromeric hemichannels that dock to hemi-
channels of the same or different composition in the plasma
membrane of contacting cells. Gap junction channels com-
posed of different connexin isoforms differ from each other in
unitary conductance and permeability to small molecules
(Harris, 2001). This raises the question of the extent to which
these channels have unique functions or can compensate for
each other.
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been described with overlapping expression patterns (cf.
Richard 2000; Kretz et al., 2004). In the mouse, Cx43, Cx40
and Cx45 are expressed in the basal layer, and Cx43 and Cx31
are expressed in the spinous layer. In the differentiating gra-
nulous layer, Cx43 disappears gradually during development,
but Cx31 is present continuously along with Cx26 (Kamibaya-
shi et al., 1993; Butterweck et al., 1994). In rat epidermis, Cx37
was localized in all epidermal layers except the stratum
corneum (Goliger and Paul, 1994). Transcripts of Cx30.3 and
Cx31.1 were found in mouse epidermis, but the expression
pattern of corresponding proteins has not yet been analyzed
(Hennemann et al., 1992; Dahl et al., 1996).
Multiple connexins in the mouse epidermis exhibit extensive
functional redundancy, since deletion of a single connexin gene
does not cause severe skin disorder (Reaume et al., 1995; Plum
et al., 2001; Kretz et al., 2003; Kibschull et al., 2005). However,
not all tissues can compensate for the loss of a connexin gene.
For example in the placenta, Cx26 deficiency led to death in
utero around embryonic day (ED) 9.5, probably due to strongly
reduced uptake of glucose by the fetus (Gabriel et al., 1998).
During pre-implantation development, several connexins,
such as Cx31, Cx31.1, Cx43 and Cx45, contribute to gap junc-
tion channels (Davies et al., 1996). After implantation, Cx31 is
characteristic of the trophoblast cell lineage, whereas Cx43 is
abundant in the embryo proper (Dahl et al., 1996). During
mouse placental development, Cx31 persists in the spongio-
trophoblast layer followed by co-expression with Cx43 at early
midgestation. Cx31 deficiency in mice causes transient pla-
cental dysmorphogenesis that leads to a loss of 60% of embryos
between ED 10.5 and ED 13.5 (Plum et al., 2001). It has been
hypothesized that Cx43 can rescue some of the homozygous
Cx31-deficient embryos, since Cx43 is induced from ED 10.5
onwards in the spongiotrophoblast cells and is upregulated in
Cx31-deficient placentas. This hypothesis could not be corro-
borated later, since Cx31 and Cx43 double-deficient mice show
no synergistic effects of both connexin channels but clearly
represent two distinct phenotypes of Cx43 and Cx31 deficiency
in the same mouse (Kibschull et al., 2005). In addition to these
placental connexins Cx31.1 mRNA expression was also
described in mouse trophoblast stem cells (Kibschull et al.,
2004), but its localization in the placenta has not yet been
analyzed. The Cx31.1 and Cx31 genes are co-localized on
mouse chromosome 4. The corresponding proteins show 65%
amino acid identity, leading to the hypothesis that these conne-
xins are probably derived by duplication of an ancestral gene
during evolution (Hennemann et al., 1992; Bennett et al., 1994).
Since Cx31.1 is expressed during pre-implantation develop-
ment and in the epidermis, we generated Cx31.1-deficent mice
in which the coding region of Cx31.1 was replaced by the lacZ
reporter gene in order to study the role of Cx31.1 in murine
development. Analysis of lacZ reporter gene expression re-
vealed that Cx31.1 is co-expressed with Cx31 throughout the
early trophoblast lineage and later in the glycogen cells of the
placenta. Thirty percent of homozygous Cx31.1-deficient
embryos died between ED 11.5 and 14.5. Like the placenta,
the body weight of surviving Cx31.1-deficient embryos wasreduced. The morphology of the Cx31.1-deficient placentas was
slightly impaired with a more compact and thickened
spongiotrophoblast labyrinth layer compared to wild-type
control. We conclude that Cx31.1 plays a critical role in early
mouse placental development.
Materials and methods
Construction of the targeting vector pCx31.1KO
A fragment of genomic 129/Sv mouse DNA spanning about 14 kb of the
Cx31.1 locus was isolated from a recombinant lambda phage library (Stratagene,
La Jolla, USA). A cosmid clone L20360 was isolated from a 129/Ola mouse
cosmid library (Resource Centre, German Human Genome Project). The Cx31.1
knockout construct was embedded in a pBluescript II SK+ vector backbone
(Stratagene). A 5.2-kb ApaI–SpeI fragment and a 1.4 BamHI–SmaI fragment
were used as 5′ and 3′ homologous region, respectively. The 400-bp fragment
between SpeI and the start codon of Cx31.1 was amplified by PCR and inserted
between the 5′ homologous region and a lacZ coding DNA with a nuclear
localization signal (NLS-lacZ, Kaestner et al., 1994). A selectionmarker cassette,
carrying the mouse phosphoglycerate kinase (PGK) promoter and a hypox-
anthine phosphoribosyltransferase (hprt) minigene (Magin et al., 1992), was
placed downstream of NLS-lacZ DNA. The selection cassette was flanked by
loxP sites, in reverse orientation with respect to the NLS-lacZ coding region (Fig.
1A). The final targeting vector pCx31.1KO was analyzed by restriction mapping
and partial sequencing. The function of loxP sites was verified by transformation
of Cre recombinase expressing E. coli bacteria (Buchholz et al., 1996).
Hprt-deficient and feeder-independent HPRT Minus (HM-1) embryonic
stem cells were transfected with 250 μg DNA of the targeting vector
pCx31.1KO and linearized upstream of the 5′ homologous region with NotI
(Magin et al., 1992). Selection of targeted ES clones using hypoxanthine–
aminopterine–thymidine (HAT) medium was performed according to standard
protocols (Selfridge et al., 1992; Theis et al., 2000).
Screening of ES cell clones
We screened HAT-resistant ES clones for homologous recombination using
PCR and Southern blot hybridization. Recombination at the 3′ homologous site
was examined using a PGK promoter specific upstream primer (QZ 6; 5′-GCT
GCTAAA GCG CAT GCT CCA GAC-3′) and a 3′ downstream primer external
to the targeting vector (QZ 7; 5′-GGATTC TCC TCT GGT CCT CTG TCC-3′)
under the following conditions: 20min of DNAdenaturation at 94 °C, addition of
1.5 U Taq DNA polymerase (Promega, Madison, WI), followed by 38 cycles of
94 °C for 30 s, 64 °C for 45 s and 72 °C for 2 min and final elongation at 72 °C for
10 min. The resulting amplicon had a size of 1.6 kb. Recombination at the 5′
homologous region was examined by Southern blot hybridization. DNA from
PCR-positive clones was digested with BamHI and fractionated by electrophor-
esis in a 0.75% agarose gel. After blotting of DNA onto Hybond™ N+ mem-
branes (Amersham Biosciences, UK), the digested DNAwas fixed by UV-cross-
linking. A 600-bp AccI/AccI fragment outside the 5′ homologous region of the
Cx31.1 gene served as an external probe and was radioactively labeled using
the Megaprime DNA Labelling System (Amersham Biosciences, UK). Hybrid-
ization was performed using Quick Hyb hybridization solution (Stratagene, La
Jolla, CA) according to instructions provided by the manufacturer. The Cx31.1
wild-type allele yielded a 10-kb fragment compared to a 14-kb fragment of
mutated allele. In addition, a 330-bp HindIII/XhoI fragment from the HPRT
coding region served as internal probe. After digestion of genomic DNA by
HindIII, the internal probe detected 2.7 kb of the mutated allele.
Karyotypic analyses were performed, and positive ES clones showing the
closest morphological similarity to the original ES cells were used for blastocyst
injection (Theis et al., 2000).
Generation of Cx31.1-deficient mice
Correctly recombined ES clones were injected into C57BL/6 blastocysts to
generate chimeras as described by Nagy et al. (2003). To obtain germ line
Fig. 1. Generation and characterization of Cx31.1-deficient mice. (A) For homologous recombination in embryonic stem cells, the targeting vector pCx31.1KO was
constructed, containing 5.2 kb 5′ homologous region and 1.4 kb 3′ homologous region of the Cx31.1 gene. The whole Cx31.1 coding region was replaced by a
promoterless lacZ reporter gene (lacZ) with nuclear localization signal (NLS) followed by a hprt gene under control of phosphoglycerate kinase (PGK) promoter.
Homologously recombined ES cell clones were injected into C57BL/6 blastocysts to generate first chimeras and in the next generation mice carrying the
Cx31.1KOhprt allele. By means of Cre activity, the selection cassette PGK-hprt was deleted, resulting in the Cx31.1KO allele, where lacZ is expressed under control
of Cx31.1 regulatory elements. (B) Southern blot analysis of BamHI digested Cx31.1+/+, Cx31.1+/− and Cx31.1−/− genomic DNA using the external Cx31.1 probe. A
10-kb fragment indicates the Cx31.1 wild-type allele, whereas a 14-kb fragment represents the mutated allele. (C) Genomic DNAwas isolated from tail biopsies of
Cx31.1+/+, Cx31.1+/− and Cx31.1−/− mice. PCR analysis was performed using primers specific for the Cx31.1 coding region and lacZ coding region, respectively, in
combination with a third primer, binding to in the 3′ homologous region. A 725-bp fragment indicates the wild-type allele and a 550-bp fragment the knockout allele.
(D) Northern blot analysis of total RNA extracted from back skin confirmed the reduction or absence of Cx31.1 transcripts in Cx31.1+/− and Cx31.1−/− mice,
respectively. The blot was hybridized to Cx31.1 coding DNA. Loading of equal amounts of total RNA was verified by rehybridizing with a glycerolaldehyde-3-
phosphate dehydrogenase-specific probe (GAPDH).
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Offspring were checked for germ line transmission by PCR including three
primers: QZ1 (5′ homologous region of Cx31.1; 5′-CTG CTT GTT CTG GGG
AGC CTC TTG-3′), QZ13 (coding region of lacZ; 5′-AAC GAC GGG ATC
ATC GCG AGC CAT-3′) and QZ17 (coding region of Cx31.1; 5′-AGG TGA
CCA GGA TGA GCT GCA GAG-3′). The PCR conditions were as follows:
5 min of DNA denaturation at 95 °C, followed by 30 cycles at 94 °C for 45 s,
60 °C for 45 s and 72 °C for 1 min and final elongation at 72 °C for 10 min. The
PCR yielded a 725-bp amplicon of wild-type and a 550-bp fragment of the
mutated allele. Heterozygous offspring, designated as Cx31.1+/−, hprt, were
crossed to female PGK-Cre mice (Lallemand et al., 1998) to generate the
genotype Cx31.1+/−. Following Cre recombinase activity, the deletion of the
HPRT-cassette was analyzed using primers QZ18 (lacZ coding region; 5′-GAG
CCC GCTAGTATC GGC GGA ATT-3′) and QZ19 (3′ homologous region of
Cx31.1; 5′-TGC GAA GTG GCC CTC GGT GTG TTT-3′) under the following
conditions: 5 min of DNA denaturation at 94 °C, followed by 35 cycles of 94 °C
for 45 s, 60 °C for 45 s and 72 °C for 1 min and final elongation at 72 °C for
7 min. A 1.5-kb amplicon indicated deletion of the HPRT-cassette. For detection
of the PGK-Cre transgene, the primers up-pgk1 (5′-GCT GTT CTC CTC TTC
CTC ATC TCC-3′) and IntCre_rev (5′-TCC ATG AGT GAA CGA ACC TGGTCG-3′) were used, generating a 500-bp amplicon under the following
conditions: 5 min of DNA denaturation at 94 °C, followed by 40 cycles of 94 °C
for 1 min, 60 °C for 1 min and 72 °C for 2 min and final elongation at 72 °C for
10 min. Cx31.1+/− mice were intercrossed, to obtain homozygously mutated
Cx31.1−/− mice. Additionally, Southern blot hybridization as described above
was used to confirm the homologous recombination.
All experiments were carried out on a mixed 129Ola/C57BL/6 genetic
background using littermates as controls. Mice were kept under standard
housing conditions with a fixed 12-h/12-h light/dark cycle and food as well as
water ad libitum. All experiments were carried out according to the German
federal law for animal welfare and with permission of local state authorities.
Mating was performed overnight and noon of the day of plug detection was
considered as embryonic day (ED) 0.5.
Southern blot analysis
For Southern blot hybridization of wild-type (Cx31.1+/+), heterozygous
(Cx31.1+/−) and homozygous (Cx31.1−/−) animals, genomic DNAwas prepared
from adult kidneys and digested with BamHI. Afterwards, genomic DNA was
fractionated on 0.7% agarose gels and transferred onto nylon membrane
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(511 bp upstream of the 5′ homologous region) was synthesized using the PCR
digoxigenin (DIG) probe Synthesis Kit (Roche diagnostics GmbH, Penzberg,
Germany) according to the manufacturer’s instructions. The upstream primer
was 5′-GTC CAC AGA GTG GGA TAC GCA GAG-3′, and the downstream
primer was 5′-CAT GTC TTG CAT GGC CAT GGG CTG-3′. Membranes were
prehybridized at 42 °C for 30 min using DIG-Easy-Hyb (Roche diagnostics
GmbH, Penzberg, Germany). Hybridization was performed overnight at 42 °C
in DIG-Easy-Hyb containing 25 ng/ml DIG-UTP-labeled DNA probes. Follow-
ing hybridization, membranes were washed two times in 2× sodium chloride/
sodium citrate solution (SSC) containing 0.1% sodium dodecyl sulphate (SDS)
for 5 min at room temperature and two times in 0.2× SSC containing 0.1% SDS
for 15 min at 68 °C. Detection was performed using DIG High Prime DNA
Labeling and Detection Starter Kit II (Roche diagnostics GmbH, Penzberg,
Germany) according to the manufacturer’s instruction. Membranes were
exposed to X-ray film (X-OMAT; Eastman Kodak).
LacZ staining of embryonic and adult tissues
Embryonic tissues were stained as whole-mounts. In brief, morulae and
blastocysts on ED 2.5 and 3.5, pregnant uteri at ED 5.5, deciduomata at ED 7.5
and 8.5 as well as embryos and placentas from ED 9.5 to ED 17.5 were fixed in
4% paraformaldehyde (PFA) in PBS for 5 to 50 min. After fixation, embryonic
tissues were washed three times in lacZ wash buffer (0.1 M phosphate buffer,
pH 7.4, 1.25 mM MgCl2, 5 mM EGTA, 0.2% Nonidet P-40 and 0.01% sodium
deoxycholate) and stained in lacZ substrate buffer (lacZ wash buffer
supplemented with 0.4 mg/ml X-Gal [5-brom-4-chloro-3-indoly-β-D-glactopyr-
anoside], 5 mM potassium ferricyanide and 5 mM potassium ferrocyanide) at
37 °C overnight. Afterwards, embryos were washed two times (5 min each),
post-fixed in 4% PFA for 1 h and washed again in lacZ wash buffer.
Adult tissues were frozen on dry ice and embedded in Tissue-Tec (Sakura,
Zoeterwoude, Netherlands). Afterwards they were sectioned (10–20 μm) with a
cryostat (MICROMHM 500 OM), air dried and transferred onto superfrost plus
slides (Menzel, Braunschweig, Germany). Then they were fixed with 0.2%
glutaraldehyde in 0.1 M phosphate-buffered saline (PBS), rinsed three times in
lacZ wash buffer and stained in lacZ substrate buffer overnight at 37 °C.
Finally, sections were washed in phosphate-buffered saline (PBS), counter-
stained in 0.1% eosin for 5 min, rinsed in distilled water, dehydrated in
increasing ethanol concentrations and mounted in Entellan (Merck, Darmstadt,
Germany).
Wild-type littermates were used to test the specificity of lacZ staining.
Western blotting
Paw skin or placental tissue was homogenized in 14 volumes of ice-cold
homogenization buffer (20 mM Tris, pH 8.0, 140 mMNaCl, 1.0% Triton X-100,
10% glycerol and 1 mM EGTA) supplemented with protease inhibitor cocktail
(Roche Diagnostics, Laval, PQ, Canada). Homogenates were briefly centrifuged
for 5 min and protein concentrations were determined using the Protein-Assay-
Kit (BioRad Laboratories, Hercules, CA). For Western blotting, 20 (skin) or 50
(placenta) μg of total protein per lane was separated on 10–12% SDS–PAGE
gels. Proteins were transferred to nitrocellulose membranes (0.2 μm) in standard
Tris–glycine transfer buffer, pH 8.3, supplemented with 0.05% SDS. The blots
were then blocked for 1 h in TBS-T (20 mM Tris, pH 8.0, 150 mM NaCl and
0.2% Tween-20) containing 5% skim milk powder. Blots were incubated
overnight at 4 °C with 1–2 μg/ml anti-Cx31.1 antibodies directed against the C-
terminus of Cx31.1 (Cat. No. 48-7800, Invitrogen/Zymed, Camarillo, CA,
USA) that was diluted in TBS-T containing 1% skim milk. After washing
extensively in TBS-T, blots were incubated for 1 h at room temperature with
horseradish peroxidase-conjugated goat anti-rabbit IgG diluted 1:5000 (Sigma),
washed and bands revealed by chemiluminescence (Amersham Biosciences
Ltd., Baie d’Urfe, PQ, Canada).
Histology
For histological analyses, placentas of ED 9.5, 10.5, 11.5, 13.5, 15.5 and
17.5 were fixed in 4% PFA in PBS overnight, washed in PBS, dehydrated inincreasing concentrations of ethanol and embedded in paraffin. Five-
micrometer sections were stained with hematoxylin and eosin and
photographs were taken using an Axiophot microscope (Zeiss, Oberkochen,
Germany).
Immunofluorescence
Animals were anesthetized with 3 ml/kg equithesin and perfused
transcardially with 3 ml of cold (4 °C) pre-fixative (50 mM sodium phosphate
buffer, pH 7.4, 0.1% sodium nitrite, 0.9% NaCl and 1 unit/ml of heparin). This
was followed by perfusion with 40 ml of fixative solution containing cold
0.16 M sodium phosphate buffer, pH 7.6, 0.2% picric acid and 4% freshly
depolymerized paraformaldehyde. Animals were then perfused with 10 ml of
cold solution containing 10% sucrose and 25 mM sodium phosphate buffer, pH
7.4. Facial skin containing nasal and whisker pad area were removed and stored
at 4 °C for 24–48 h in cryoprotectant (25 mM sodium phosphate buffer, pH 7.4,
10% sucrose, 0.04% sodium azide). Sections were cut on a cryostat at a
thickness of 10 μm, collected on gelatinized glass slides and processed for
immunofluorescence staining with Cx31.1 antibodies diluted in TBS-T (50 mM
of Tris–HCl, pH 7.4, containing 1.5% sodium chloride, 0.3% Triton X-100) and
5% normal goat serum. Sections were incubated for 24 h at 4 °C with polyclonal
anti-Cx31.1, then washed for 1 h in TBS-T, incubated with secondary antibodies
for 1.5 h at room temperature, then washed in TBS-T for 20 min, followed by
two 15-min washes in 50 mM Tris–HCl buffer, pH 7.4. As secondary
antibodies, we used AlexaFlour 488-conjugated goat anti-rabbit IgG diluted
1:1000 (Molecular Probes, Eugene, Oregon). Sections were coverslipped with
antifade medium. Laser scanning confocal analysis was conducted with an
Olympus Fluoview IX70 confocal microscope and images were obtained using
Olympus Fluoview software. Final images were assembled using CorelDraw
Graphics Suite 12 (Corel Corp., Ottawa, Canada) and Adobe Photoshop CS
(Adobe Systems, San Jose, CA, USA).
Periodic acid Schiff reaction
For detection of stored glycogen in placental glycogen cells, periodic acid
Schiff (PAS) reaction was performed. Paraffin sections of whole-mount lacZ-
stained placentas were rehydrated and incubated in 0.5% periodic acid solution
for 15 min. After a short wash with distilled water, specimens were transferred to
Schiff’s reagent (Merck, Darmstadt, Germany) for 20 min and afterwards
washed in warm running tap water for 15 min. After dehydration, stained
sections were mounted in Entellan.
In situ hybridization
In situ hybridization experiments were performed as recently described
(Zheng-Fischhöfer et al., 2007).
Morphometry
Each of 3 WT and 3 KO placentas on ED10.5 have been analyzed. From
each placenta 3 independent cross sections in the middle around the insertion of
the umbilical cord were analyzed. The thickness of the labyrinth and
spongiotrophoblast layer was measured at a minimum of 8 positions per slide.
To quantify vascularization in the labyrinth layer, the area of all fetal blood
vessels or all maternal blood spaces, respectively, was evaluated per slide and
related to the total area of the labyrinth layer on the same slide. Data are shown
as means and have been subjected to statistical tests.
Statistics
Data are presented as means±standard deviation (SD). The weights of
embryos as well as placentas and the placental morphometry were analyzed with
the Mann–Whitney test for the non-parametric independent two-group
comparisons applying the program SPSS 14 for Windows (SPSS Inc., Chicago,
Illinois) and GraphPad Prism 4 for Windows (GraphPad Software Inc.,
California, San Diego). Differences with P≤0.05 were regarded as statistically
significant.
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Generation of mice
Cx31.1-deficient mice were generated using a targeting cons-
truct in which the whole coding region of Cx31.1 immediatelyFig. 2.Cx31.1 expression analyzed by staining for lacZ reporter gene during themouse pre
Analysis of lacZ expression was performed at the following stages: (A) morula, ED 2.5
ED 15.5. Western blot analysis confirmed that Cx31.1 protein is expressed in ED 13.5 p
deficient (−/−) placentas. Molecular weight standards (15, 25, 30 and 50 kDa) are indic
embryos (A, B). After implantation, Cx31.1 was expressed in all subpopulations of th
When the trophoblast cells differentiate into the different placental trophoblast populatio
cells of the spongiotrophoblast (S) and the labyrinth (L) but not in the labyrinthine syncy
expressionwas downregulated in the spongiotrophoblast cells (G) and is induced again i
(H, I). Expression of Cx31.1 in glycogen cells was confirmed by periodic acid Schiff redownstream of the start codon was replaced by a promoter-less
lacZ reporter gene with a nuclear localization signal and an hprt
minigene under the control of the PGK promoter (Fig. 1A). After
transfection, 17% HAT resistant ES clones showed homologous
recombination (based on Southern blot hybridization), i.e. at a
frequency of 17%. After injection into blastocysts, one clone(A, B)- and post-implantation phase (C,D) and during placental development (F–K).
; (B) blastocyst, ED 3.5; (C) ED 6.5; (D) ED 8.5; (F) ED 9.5; (G) ED 11.5; (H–K)
lacentas of wild-type (+/+) and heterozygous (+/−) mice but absent from Cx31.1-
ated. (E). No expression of the lacZ reporter gene was detected in pre-implantation
e trophoblast cell lineage (ectoplacental cone, EC), but not in the epiblast (C, D).
ns around ED 9.5 of gestation, expression has been transiently found in the diploid
tiotrophoblast or trophoblast giant cells (F). Later in placental development,Cx31.1
n placental glycogen cells (GC), which develop in themouse placenta after ED11.5
action showing glycogen as magenta-colored reaction product (J, K). D, decidua.
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deficient hprt mice (Cx31.1+/−, hprt). Male Cx31.1+/−, hprt mice
were mated with female PGK-Cre mice. Cre activity commences
in the diploid phase of oogenesis (Lallemand et al., 1998). The
Cre-mediated recombination led to excision of the selection
cassette PGK-hprt. Interbreeding of heterozygous Cx31.1-de-
ficient mice (Cx31.1+/−) resulted in viable homozygous Cx31.1-
deficient mice (Cx31.1−/−) as proven by Southern blot (Fig. 1B),
PCR (Fig. 1C) and Northern blot hybridizations (Fig. 1D).
LacZ reporter gene expression in the heterozygous
Cx31.1-deficent mice during embryogenesis
The spatio-temporal expression of Cx31.1 was analyzed by
staining several tissues for lacZ reporter gene activity. In pre-
implantation embryos no lacZ reporter gene activity could be
detected (Figs. 2A, B). In the post-implantation embryo, lacZ
expression was only present in the derivatives of trophoblast
cell lineage: the ectoplacental cone and the extraembryonic ec-
toderm, but absent from the epiblast (Figs. 2C, D). This pattern
was maintained up to formation of the chorioallantoic placenta.
After formation of the chorioallantoic placenta, lacZ was tran-
siently expressed in diploid cells of the spongiotrophoblast from
ED 9.5 onwards. Staining was absent from the multinucleated
syncytiotrophoblast in the labyrinth layer (Fig. 2F). During
ongoing placental development, lacZ expression was gradually
suppressed in cells of the spongiotrophoblast and disappeared
by ED 11.5. However, expression persisted in a subpopulation
of trophoblast cells, the so-called placental glycogen cells,Fig. 3. Cx31.1 expression analyzed by staining for lacZ reporter gene and counter stai
Cx31.1+/− embryo. (B) Cryosection of ED 15.5 Cx31.1+/− embryonic back skin. L
sections of the ED 13.5 Cx31.1+/− embryo. M, mantle layer of the midbrain; R, roowhich first appear in the mouse placenta around ED 11.5 (Fig.
2G). In the mature placenta (ED13.5) all glycogen cells were
positive for Cx31.1/lacZ staining (Figs. 2H, I) and Cx31.1
protein expression was confirmed by Western blotting. The
specific Cx31.1 signal was absent from a Cx31.1-deficient
placenta (Fig. 2E). The expression of Cx31.1 in glycogen cells
has been proven by glycogen detecting PAS staining in com-
bination with lacZ staining (Figs. 2J, K). Thus, there is a
difference in the expression pattern of Cx31 and Cx31.1 in so
far as Cx31.1 is suppressed in the spongiotrophoblast around
ED 11.5 but remains in glycogen cells (Figs. 2G, H).
In the embryo proper, β-galactosidase activity was found in
the mantle layer of the midbrain (Figs. 3A, D) and the rootlet of
trigeminus nerves up to ED 11.5 (Figs. 3A, E). In the epidermis,
lacZ staining was first detected on ED 15.5 (Fig. 3B).
Strong lacZ staining was detected in the vomeronasal organ
(Figs. 3A, C) and the primitive nasal cavity (Figs. 3A, C). Cor-
responding wild-type samples were stained in parallel as nega-
tive controls (data not shown).
Cx31.1 expression in the skin of adult mice
In the epidermis of adult mice, lacZ/Cx31.1 expression was
detected in the suprabasal layers (spinous layer, granular layer
and stratum corneum), but not in the basal layer (Fig. 4A). In
addition, positive lacZ staining was found in the hair follicles
and sebaceous glands (data not shown). Cx31.1 protein expres-
sion was confirmed by Western blot analysis on paw skin
showing a specific signal in wild-type and heterozygous, but notning with eosin in Cx31.1+/− embryos. (A) Whole-mount staining of an ED 13.5
acZ staining was detected in some suprabasal keratinocytes. (C–E) Transverse
tlets of trigeminal nerve; VNO, vomeronasal organ; P, primitive nasal cavity.
Fig. 4. Cx31.1 expression in adult mouse skin. LacZ/Cx31.1 is expressed in suprabasal epidermal layers of tail skin in Cx31.1+/− mice (A). Western blotting confirms
Cx31.1 protein expression in wild-type (+/+) and heterozygous (+/−) mice but shows absence of a signal in Cx31.1-deficient (−/−) mice. Molecular weight standards
(18, 28 and 37 kDa) are indicated (B). Immunofluorescence labeling of Cx31.1 in adult mouse facial skin confirms dense labeling restricted to the epidermal layer of
skin from a wild-type mouse (C, arrows) and absence of labeling for Cx31.1 in a similar field of skin from a Cx31.1-deficient mouse (D, arrows). Higher magnification
of tangential skin sections from a wild-type mouse shows punctated appearance of immunolabeling for Cx31.1 localized in gap junction plaques around cells (E, F
arrows). On hematoxylin- and eosin-stained paraffin sections of adult tail skin, no histological difference was observed between Cx31.1+/+ (G) and Cx31.1−/− (H)
epidermis. The thickness of the stratum corneum was not significantly different between Cx31.1+/+ and Cx31.1−/− tail skin.
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beling for Cx31.1 in facial skin area revealed that specific
reactivity was restricted to the epidermis based on comparisons
of immunolabeling patterns in skin from wild-type (Figs. 4C, E,
F) and Cx31.1-deficient (Fig. 4D) mice. Specific immunolabel-
ing was deduced based on its absence from the skin in Cx31.1-
deficient mice. Labeling for Cx31.1 appeared to be most con-
centrated in the suprabasal cell layers as seen in sections taken
perpendicular to the skin surface (Fig. 4C) and consisted of
Cx31.1-positive punctated immunosignals densely distributed
around cells in these layers, as seen by laser scanning confocal
immunofluorescence in sections taken tangentially to the skin
surface (Figs. 4E, F). Histological analysis of the epidermis did
not show any obvious phenotypic alteration in adult Cx31.1−/−
mice (Figs. 4G, H) when compared to wild-type littermates. No
differences in the expression of epidermal markers of differ-
entiation, namely keratin 1, keratin 5 and loricrin, were foundbetween wild-type and Cx31.1-deficient mice by immunofluor-
escence analysis (data not shown). We also analyzed wound
healing in the epidermis of Cx31.1-deficient mice (cf. Kretz et
al., 2003). After wounding, neither the expression pattern of
other connexins in the epidermis (Cx26, Cx30, Cx31 and Cx43)
nor the process of wound healing was obviously altered in the
Cx31.1-deficient mice.
LacZ/Cx31.1 expression in chemosensory subsystems of adult
mice
In cross sections through the nose of Cx31.1+/− mice, strong
X-Gal staining was visible in distinct regions of the olfactory
epithelium (Fig. 5A). The areas comprising labeled cells were
distributed along the dorsal part of the nasal septum and the
dorsal recess. Additional staining was detected at the tip of the
endoturbinates II and III and on ectoturbinate 2. Thus, reactive
Fig. 5. Cx31.1 expression in chemosensory subsystems. Cross section through the nose of a Cx31.1+/−mouse stained by X-Gal and counterstained with eosin. (A) The
nasal septum and the turbinates of the left nasal cavity are shown. LacZ-positive cells were detected in subregions of the olfactory epithelium located in the dorsal zone
of the nose. n, nasal septum, 2 and 3, ectoturbinates; II–IV, endoturbinates. Dorsal is to the top, lateral to the left. Scale bar: 500 μm. (B) Whole-mount preparation of
the nasal turbinates from the left nasal cavity. lacZ cells were restricted to the dorsal zone of the olfactory epithelium located adjacent to the olfactory bulb (ob). The
cells are spread along the anterior–posterior axis of the nose. No labeling was detected in the respiratory epithelium (r). Anterior is to the left, dorsal to the top. The
vertical line indicates the approximate plane of the cross section shown in panel A. (C) Segment of the olfactory epithelium from the dorsal zone. Cx31.1 expressing
cells were restricted to the layer of olfactory sensory (os) cells. No expression was detected in the sustentacular cells (sus) and in the lamina propria (lp). nl, nasal
lumen. Scale bar: 50 μm. (D) Cross section through the vomeronasal organ (VNO). Cx31.1 expressing neurons were detected in the apical layer of the sensory
epithelium (s) close to the lumen (vl), but not in the non-sensory (ns) part of the VNO. Scale bar: 100 μm. (E) Adjacent cross section to (D) shows in situ hybridization
using an antisense riboprobe to V1Ra5, a member of the V1R-family of vomeronasal chemosensory receptors. V1Ra5 expressing neurons are restricted to the apical
layer of the VNO sensory epithelium, similar to the distribution of Cx31.1 expressing cells shown in panel D. Scale bar: 100 μm.
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lium, whereas the ventral and lateral parts of the olfactory epi-
thelium contained no lacZ-labeled cells. To further characterize
the distribution of Cx31.1 expressing cells in the olfactory epi-
thelium, whole-mount preparations of the nasal turbinates were
stained with X-Gal (Fig. 5B). This observation confirmed the
notion that Cx31.1 expressing cells were exclusively localized
in the olfactory epithelium. No expression was detected in the
respiratory epithelium or in the olfactory bulb. A higher mag-
nification of a cross section through the olfactory epithelium
(Fig. 5C) also revealed that Cx31.1 expressing cells were
restricted to the layer of the olfactory receptor cells. Staining
was neither visible in the most apical layer of the epithelium,
where the sustentacular cells are localized, nor in the underlying
lamina propria.
LacZ/Cx31.1-positive cells were also detected in the vome-
ronasal organ (VNO), the second chemosensory subsystem of
the mouse (Fig. 5D). A subpopulation of cells in the sensoryepithelium was lacZ stained, whereas no labeling was detected
in the non-sensory part of the organ. A closer inspection of the
Cx31.1 expressing cells revealed that they were not homo-
geneously distributed throughout the entire layer of the sensory
epithelium but restricted to the apical portion close to the lumen
of the organ. This pattern was similar to the one observed for
VNO neurons, which express defined members of the V1R-
family of vomeronasal chemosensory receptors. In situ hybrid-
ization experiments using a V1Ra5-specific antisense riboprobe
indeed resulted in an identical distribution pattern for the
labeled neurons (Fig. 5E), strongly suggesting that the Cx31.1
expressing cells in the VNO might represent a subgroup of V1R
expressing neurons in this organ.
Furthermore, we investigated the hearing capability of
Cx31.1-deficient mice, as described for other connexin mutants
(Zheng-Fischhoefer et al., 2007) and found normal auditory
thresholds as measured by brain stem evoked potentials (data not
shown).
Fig. 6. Embryo survival and growth rates between ED 11.5 and 18.5. (A)
Embryonic survival rate after mating of Cx31.1+/+ or Cx31.1−/− mice with the
same genetic background, monitored as the ratio of living embryos. A minimum
of 13 embryos per day and genotype has been used. Weight of placentas (B) and
embryos (C) after mating of Cx31.1+/+, Cx31.1+/− and Cx31.1−/− mice,
respectively. For each day, between 12–82 wild-type and 19–78 Cx31.1-
deficient samples were analyzed. All weights are indicated as mean±SD.
Asterisks indicate time points where the values differed significantly: *Pb0.05;
**Pb0.01; ***Pb0.001.
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In order to obtain Cx31.1−/− mice, Cx31.1+/− mice were
intercrossed. Cx31.1-deficient mice were viable; however,
approximately 30% of Cx31.1-deficient embryos were lost
between ED 11.5 and ED 14.5 of pregnancy indicated by the
presence of dead conceptuses in the uterus (Fig. 6A). The
weight of the placentas of living Cx31.1-deficient embryos was
significantly reduced from ED 12.5 onwards to the end of
pregnancy when compared to wild-type controls (Fig. 6B).
From ED 12.5 to 18.5, the Cx31.1-deficient placentas on ave-
rage showed 85% of the weight of the wild-type placentas. This
reduction in placental weight led to a significant reduction in
embryonic weight only on ED 17.5 and 18.5: On ED 17.5 the
Cx31.1-deficient embryos showed 93% of the weight of a
wild-type embryo and this was further reduced to 88% of
weight by ED 18.5 (Fig. 6C). This suggests that the Cx31.1-
deficient placentas were not able to feed the growing embryos
appropriately.
Evaluation of the placental phenotype
Histological analysis of the Cx31.1-deficient placenta at ED
9.5 revealed no obvious differences in morphology compared to
the wild-type placenta (data not shown). However, 1 day later at
ED 10.5 the alterations in placental morphology became more
apparent. Though all three trophoblast layers (labyrinth, spo-
ngiotrophoblast and giant cells) have been developed in the
Cx31.1-deficient placenta (Figs. 7A, B), the differentiation
pattern seemed to be impaired. The thickness of the spongio-
trophoblast layer was increased (Tab. 1) and appeared more
compact compared to the wild-type controls (Figs. 7C, D). Most
of the spongiotrophoblast cells revealed a two-fold increase in
diameter and showed increased volumes of the nuclei. The
spongiotrophoblast cells were not arranged in nests but instead
formed some a shell with very few and small lacunae remaining
for the maternal blood supply (Figs. 7B, D). Furthermore,
within the labyrinth, the inter-labyrinthine spaces, filled with
maternal blood, tended towards reduced sizes and conversely
the diameter of the fetal vessels tended towards increased areas,
compared to the wild-type controls (Figs. 7E, F). However,
these findings were not statistically significant (Table 1).
On ED 13.5, the spongiotrophoblast was still more compact
with reduced lacunae for maternal blood flow compared to wild-
type placentas (Figs. 8A–D). In both wild-type and Cx31.1-
deficient placentas, the glycogen cells were differentiated
within the spongiotrophoblast and started to invade the decidua
(Figs. 8B, D). Since Cx31 and Cx31.1 are co-expressed in the
post-implantation trophoblast cell lineage and show similar
placental phenotypes, we investigated if deletion of the Cx31.1
gene affected the level of Cx31 expression. Western blot
analysis of Cx31 protein expression indicated that the lack of
Cx31.1 in the placenta did not lead to a change of Cx31 protein
expression (data not shown).
Although Cx31.1 expression at this developmental stage was
clearly shifted to the glycogen cell population (Figs. 2G, H),
there were no obvious differences in the amount, temporal
Fig. 7. Morphology of wild-type (A, C, E) and Cx31.1-deficient placentas (B, D, F) at ED 10.5 after H&E-staining. All layers of the Cx31.1-deficient placenta (B) were
developed similar to the placenta of wild-type animals (A). However, higher magnification reveals that the spongiotrophoblast is morphologically different in the
Cx31.1−/− placenta. The cells are enlarged (D) and in contrast to the wild-type spongiotrophoblast (C) they are more compactly arranged and form only small spaces for
maternal blood flow. The labyrinth in the Cx31.1-deficient placenta (F) looks normal in extent; however, embryonic vessels tend to be bigger in diameter (arrowhead),
whereas the inter-labyrinthine space with maternal blood is smaller (arrow) compared to the wild-type labyrinth (E). S, spongiotrophoblast; L, labyrinth.
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Cx31.1-deficient placenta (Figs. 8E, F).
Thus, the loss of Cx31.1 impairs differentiation in the
trophoblast cell lineage during placental development, affecting
the spongiotrophoblast layer. This phenotype is similar to theTable 1
(A) Thickness of the labyrinth and spongiotrophoblast layer in Cx31.1 knockout
placenta at ED 10.5 compared to wild-type controls and (B) relative areas of
fetal blood vessels and maternal sinusoids compared to total labyrinth areas
Variable Group
WT KO
(A)
Thickness of labyrinth layer (μm) 230.1±33.8 298.1±80.8
Thickness of spongiotrophoblast layer (μm) 75.5±22.2* 158.4±48.5*
(B)
Relative area of fetal vessels in the labyrinth
layer (%)
1.2±0.8 1.8±2.0
Relative area of maternal lacunas in the
labyrinth layer (%)
2.1±3 1.3±1.2
∗ Significant difference Mann–Whitney test Pb0.001.Cx31-deficient mouse but the effects are less dramatic. How-
ever, on the basis of the morphological alterations observed, it is
not possible to predict, which Cx31.1-deficient placenta will
lead to the death of the embryo and which will allow embryo
survival, as it could be forecasted for placental development in
the Cx31-deficient mouse (Plum et al., 2001).
Since glycogen cell development was not impaired in
Cx31.1-deficient mice, we further investigated the expression
of the other placental connexins (i.e. Cx26 and Cx43) in gly-
cogen cells for redundancy. LacZ staining revealed Cx31 ex-
pression throughout the spongiotrophoblast and glycogen cells
(Figs. 9A, B), but Cx26 and Cx43 were not expressed in
glycogen cells (Figs. 9C–F).
Discussion
Deletion of the Cx31.1 gene in the mouse has demonstrated
that this member of the connexin multigene family contributes
to normal mouse placental development.
Using the lacZ reporter gene as an indicator of Cx31.1
expression, we found that Cx31.1 and Cx31 exhibit overlapping
Fig. 8. Placenta of wild-type (A, B, E) and Cx31.1-deficient mouse (C, D, F) on ED 13.5 (A–D) and on ED 15.5 (E, F) H&E staining. Compared to a wild-type
placenta (A, B) on ED 13.5 the spongiotrophoblast of the Cx31.1-deficient placenta (C, D) is still more compact and reveals less sinusoid spaces. In both the Cx31.1-
deficient and the wild-type placenta, glycogen cells are developed. On ED 15.5, the spongiotrophoblast of Cx31.1-deficient (F) and wild-type placenta (E) exhibit well-
developed fields of glycogen cells. S, spongiotrophoblast; L, labyrinth; GC, glycogen cells.
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lineage, such as the extraembryonic ectoderm, the ectoplacental
cone and also in spongiotrophoblast and glycogen cells of the
placenta. However, there are also differences in expression of
both connexins. Cx31.1 is suppressed in the spongiotrophoblast
cells after ED 10.5 and is restricted to the placental glycogen
cells. In contrast, Cx31 expression is maintained in spongio-
trophoblast cells until the end of pregnancy (Plum et al., 2001),
including the subpopulation of glycogen cells as specified in the
present study. Another difference is the temporal expression of
these two connexins in pre-implantation embryos. Cx31 is ex-
pressed in compacting morulae (Plum et al., 2001), whereas
Cx31.1 expression is induced in the post-implantation tropho-
blast. Furthermore, the targeted ES cells used to generate the
Cx31.1-deficient mouse did not express the lacZ reporter gene
(data not shown).
Previously it was demonstrated that Cx31.1 protein as-
sembled into gap junction plaques in compacting pre-implanta-
tion embryos (Davies et al. 1996) and blastocysts using specific
antibodies (Houghton et al., 2002; Goliger and Paul, 1994).
There are at least 9 other connexins expressed in pre-implan-
tation mouse embryos, each showing a different time of gene
expression onset. The absence of each of them does not interfere
with development as shown by characterizations of the specificconnexin-deficient mice (De Sousa et al., 1997; reviewed by
Houghton, 2005). Moreover, blastocyst development can be
achieved in vitro in the presence of inhibitors of gap junctional
intercellular communication (De Sousa et al., 1997). Since
Cx31.1 is also not essential for the pre-implantation develop-
ment and the peri-implantation phase, it might be possible that
the onset of Cx31.1 expression varies between different mouse
strains, which could explain the differences in Cx31.1 detection
in previous work (Houghton et al., 2002). The expression of
Cx31.1 in the trophoblast cell lineage was first described in an
analysis of murine trophoblast stem cell differentiation by
Kibschull et al. (2004). Trophoblast stem cell lines are derived
from outgrowths of the blastocyst’s trophectoderm and show
marker gene expression of the extraembryonic ectoderm
(Tanaka et al., 1998). Consistently, they show expression of
the post-implantation specific Cx31.1 gene (Kibschull et al.,
2004). The expression profile of Cx31.1 during trophoblast
stem cell differentiation was nearly identical to the profile of
Cx31, which is known to regulate trophoblast cell lineage
development (Plum et al., 2001).
Both connexin genes co-localize on the distal part of mouse
chromosome 4, only 25 kbp apart from each other and are
probably derived by duplication of an ancestral gene during
evolution (Hennemann et al., 1992). The divergent expression
Fig. 9. Connexin expression in glycogen cells. Placental glycogen cells express Cx31, shown by lacZ expression in a Cx31+/lacZ placenta at ED 13.5 (A, B). LacZ
staining characterizes the diploid cells of the chorionic plate and the spongiotrophoblast and the glycogen cell clusters. Immunofluorescence (C, E) and corresponding
phase-contrast images (D, F) of wild-type placenta sections using antibodies to Cx43 (C) and Cx26 (E). Cx43 was expressed in the spongiotrophoblast and the decidua
but not in glycogen cells, as shown by immunolabeling (C, D). Cx26 was expressed in the labyrinthine syncytiotrophoblast, but absent from glycogen cells (E, F). D,
decidua; CP, chorionic plate; S, spongiotrophoblast; L, labyrinth; GC, glycogen cells.
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specific mechanisms of gene expression in this genomic locus.
Like Cx31-deficient mice, Cx31.1-deficient embryos die
within a 3-day window during the second half of gestation when
the chorioallantoic placenta is formed. The death of the Cx31.1-
deficient embryos starts 1 day later than observed in the Cx31-
deficient mouse. Only 30% of the Cx31.1-deficient embryos
died in utero, whereas a 60% loss of embryos was found in the
Cx31-deficient mouse (Plum et al., 2001).
Both Cx31.1 and Cx31 contribute to trophoblast lineage
differentiation but to a different extent. Whereas the loss of
Cx31 causes an early visible dysmorphogenesis of the early
placenta with enhanced differentiation along the giant cell
pathway resulting in reduced stem cells, labyrinth and spongio-
trophoblast layers (Plum et al., 2001; Kibschull et al., 2004), the
morphogenesis of the Cx31.1-deficient placenta is only slightly
impaired. Furthermore, in contrast to the Cx31-deficient pla-
centa, where formation of the labyrinth and spongiotrophoblast
layers is strongly affected, the Cx31.1-deficient placenta shows
less obvious alterations. The enlarged cells of the spongio-
trophoblast form a tight shell at the border of the decidua, and
the fetal vessels of the labyrinth tend to be enlarged. Whether
this dilatation is a rescue process due to impaired nutrition of the
embryos by altered maternal blood circulation in the placenta
remains to be elucidated. Clearly the surviving embryos aregrowth restricted at the end of pregnancy indicating that the
Cx31.1-deficient placenta cannot feed the growing embryos
sufficiently during this late embryonic phase due to its reduced
size. Thus, the Cx31.1-deficient phenotype affects all placentas
but to a different extent; strongly affected embryos die after ED
11.5, while milder affected surviving embryos are growth
restricted. It is likely that Cx31 can compensate for the loss of
Cx31.1 to a certain degree. This hypothesis will be verified in the
future by generating a Cx31/Cx31.1 double-deficient mouse.
Although Cx31.1 in the spongiotrophoblast cells is sup-
pressed after ED 10.5 and exclusively expressed in glycogen
cells later in pregnancy, this cell population seems to develop
normally. Glycogen cells are characterized by the storage of
glycogen and mediate the interstitial invasion into the decidua
after midgestation (Adamson et al., 2002). Though several
marker genes have been identified, little is known about their
function (Simmons and Cross, 2005). Glycogen cells become
the major source of insulin-like growth factor (IGF)-II ex-
pression in the second half of gestation, which is thought to
promote blood flow in the labyrinth layer (Redline et al., 1993).
A role of Cx31.1 in glycogen cell function or interstitial in-
vasion is likely but does not seem to interfere with the death of
the embryos, since the defect can be seen before these cells are
differentiated in the placenta after ED 11.5. In addition, IGF-II-
deficient mice are growth restricted and show a reduced
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1996). Moreover, the lack of IGF-II reduces the number of
differentiated glycogen cells in the placenta (Lopez et al., 1996),
which is not the case in the Cx31.1-deficient placenta. Thus, the
absence of Cx31.1 alone does not seem to abolish IGF-II ex-
pression in glycogen cells. Since Cx31 is co-expressed in gly-
cogen cells, overlapping functions for both connexins in this
cell type are possible.
Cx31.1 has been described to be predominantly expressed in
the skin (Hennemann et al., 1992). Cx31.1-deficient mice
showed normal morphology of the epidermis. LacZ staining
indicated that Cx31.1 was expressed in the spinous and granular
layers of the epidermis. Specific beta-galactosidase activity was
also found in the cornified layers of the epidermis, possibly due
to the high stability of the bacterial enzyme in transgenic mice.
In order to analyze the effect of Cx31.1 on wound healing, we
incised wounds into the mouse tail as previously described
(Kretz et al., 2003), but no significant changes in the process of
wound healing were found in Cx31.1-deficient mice compared
to controls. We conclude that similar to Cx31-deficient mice
(Plum et al., 2001), Cx31.1 deficiency does not result in any
obvious morphological and functional disorder in the epidermis.
Our results support the general assumption that there is an
extensive functional redundancy between the different connexin
isoforms in the mouse epidermis.
Strong lacZ staining was also observed in the olfactory epi-
thelium and the vomeronasal organ. Possible consequences of
Cx31.1 deficiency in these tissues will be studied in behavioral
experiments.
In conclusion, Cx31.1 is important for early placental deve-
lopment. In the embryo proper and in adult mice, its loss can
apparently be compensated, leading to normal development.
The strong functional redundancy among different connexins
can be further analyzed in mice with multiple connexin null
alleles or by generation of transgenic mice expressing mutated
connexins which exert a transdominant-negative influence on
other connexins.
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